Young KIM

Patent Litigation.

Young Kim handles numerous patent litigations in pharmaceutical, biotech, chemical, polymers, optical products, glasses and electronic materials. She has handled many landmark patent cases, including Supreme Court cases involving issues of an indirect infringement, inventive step for a chemical invention, infringement under doctrine of equivalents, description requirements for a pharmaceutical invention, improper hindsight bias, and patentability of a selection invention. She also serves on the domain name panelist of WIPO. She has been a guest speaker at various conferences including IPO, AIPLA and AIPPI.

Pennsylvania Bar and District of Columbia Bar;

Korea Patent Attorneys Association.

Patent Enforcement in the UK and Trans-Pacific Countries: Korean Chapter (Global Law and Business, 2021);

International Patent Litigation: Korean Chapter (BNA, 2018-2020);

Practical Law’s Global Guide: Korean Chapter (Thomson Reuters, 2018);

Pfizer Gets First Generics Ban Under Korea Patent Linkage Law (Bloomberg BNA, 2016.9.);

Korea Supreme Court Upholds Validity of Pfizer’s Lyrica Patent (Bloomberg BNA, 2016.5.);

First Korean Court Finding of Infringement Against Generic Over Unlabeled Indication (BNA, 2014);

Supreme Court Upholds Validity of Selection Invention Patent for the First Time (ILO, 2012).

Franklin Pierce Law Center (J.D., 1993);

Seoul National University (B.S., Pharmacy, 1977).